Select Page

MyPeBS
is an international

EU-funded clinical study
that evaluates a new breast cancer screening strategy

9
4
5

Women
included in
the study so far

What is MyPeBS ?

MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 5 countries: Belgium, France, Israel, Italy, and United Kingdom.

MyPeBS (My Personal Breast Screening) is a major ambitious European initiative. This unique international clinical study compares a personalised risk-based screening strategy (based on the individual women’s risk of developing breast cancer) to standard screening among 85,000 women aged 40 to 70 in 5 countries: Belgium, France, Israel, Italy, and United Kingdom.

Animation video presenting the MyPeBS study

News

Participation of MyPeBS team in the first edition of ENVISION

Participation of MyPeBS team in the first edition of ENVISION

The first European conference on risk-stratified prevention and early detection of breast cancer was held from 26 to 28 June 2019 in Austria. The main objective was to pool knowledge and set actions towards implementation of risk-based breast cancer prevention and...

read more
Recent publications by the MyPeBS team

Recent publications by the MyPeBS team

We are proud to share these recent relevant publications by the teams involved in MyPeBS consortium Manchester team highlighted for the first time, the ability of a risk model (Tyrer Cuzick) including density and SNPs not only to predict for breast cancer risk, but...

read more

Partners

Members of the MyPeBS Consortium
Associated partners
Members of the MyPeBS Consortium
Associated partners
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium
Members of the MyPeBS Consortium

The MyPeBS study is supported by the French Health Insurance and the French National Cancer Institute (INCa), and has been approved by the Cancer Screening Strategic Committee chaired by the French General Director of Health.